(Q49018893)

17 February 2018

title

Ocular Pigmentation, Extrapyramidal Symptoms and Phenothiazine Dosage (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

1 July 2023

main subject

extrapyramidal symptoms

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5806859

1 July 2023

1

R H Wheeler

1 reference

17 February 2018

V R Bhalerao

2

object named as

V R Bhalerao

1 reference

17 February 2018

M J Gilkes

3

object named as

M J Gilkes

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 June 1969

1 reference

17 February 2018

full work available at URL

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000101837

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

British Journal of Psychiatry

1 July 2023

published in

1 reference

17 February 2018

volume

115

1 reference

17 February 2018

issue

523

1 reference

17 February 2018

page(s)

687-690

1 reference

17 February 2018

OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE

1 July 2023

2

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

Eye and skin changes in psychiatric patients treated with chlorpromazine

1 July 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

Phenothiazines and eye complications.

1 July 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

LENTICULAR OPACITIES WITH PROLONGED PHENOTHIAZINE THERAPY: A POTENTIAL HAZARD WITH ALL PHENOTHIAZINE DERIVATIVES

1 July 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY.

1 July 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE

1 July 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

OCULOCUTANEOUS EFFECTS OF CHLORPROMAZINE

1 July 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

Skin and eye changes associated with chlorpromazine therapy.

1 July 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY

1 July 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

The ocular toxic findings with prolonged and high dosage chlorpromazine intake

1 July 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

A CLINICAL STUDY OF PIGMENTARY CHANGE IN CORNEA AND LENS IN CHRONIC CHLORPROMAZINE THERAPY.

1 July 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.115.523.687

1 July 2023

Identifiers

1 reference

17 February 2018

1 reference

17 February 2018